Skip to content
WeighLab
Menu
Ranked #99 · Grade C

eMI Aesthetics review

eMI Aesthetics is a direct-to-consumer telehealth brand offering compounded semaglutide (injection or oral) and tirzepatide in all 50 states.

Visit eMI Aesthetics Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$179/mo (compounded)
Tirzepatide
$269/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$2,148

Tirzepatide · modeled / year

$3,228

Pricing verified August 2026

The Index scorecard

eMI Aesthetics scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month76/100
Price Transparency38/100
Nationwide Access86/100
Formulation Options90/100
Clinical Oversight70/100
Contract Flexibility55/100

Where the value is

  • Available to eligible patients in all 50 U.S. states per the site's own GLP-1 program page
  • Offers semaglutide in both injectable and oral form, plus tirzepatide, on one platform
  • Full program cost is bundled — evaluation, medication, delivery, coaching, and follow-up with no separate fees itemized
  • Intake runs through OpenLoop Health, an established third-party telehealth clinician network

The tradeoffs

  • The advertised '$179/month' is the FLOOR of a $179-$249 range for the injection alone; oral semaglutide runs $209-$279 and tirzepatide $269-$339 — the actual price a patient pays isn't disclosed before intake
  • No specific dispensing pharmacy is named
  • No individually named prescriber or medical director — clinicians are sourced through the third-party OpenLoop Health network
  • No LegitScript certification found on the pages read

The bottom line

Best for: Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote. eMI Aesthetics is a direct-to-consumer telehealth brand offering compounded semaglutide (injection or oral) and tirzepatide in all 50 states.

Ranked #99 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to eMI Aesthetics.

The 18 programs nearest this one

Pricing, states and verification reflect eMI Aesthetics's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on eMI Aesthetics's site. Not medical advice; see our disclosure.

← Back to the value leaderboard